Key Insights

Highlights

Treatment Research

2 treatments under study, led by Bromfenac Sodium

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Phase 2 (1)
Phase 4 (1)

Trial Status

Recruiting1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06520410Phase 4Recruiting

Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries

NCT05107921Phase 2UnknownPrimary

Bromfenac Sodium Hydrate Eye Drops in Familial Exudative Vitreoretinopathy

Showing all 2 trials

Research Network

Common Treatments

  • Bromfenac Sodium1
  • Pars Plana Vitrectomy With A 18 Mm Short Vitrector1

Active Sponsors

  • Chang Gung Memorial Hospital1
  • Seoul National University Hospital1

Top Investigators

Related Conditions

  • Retinal Disease1
  • Coats Retinopathy1
  • Vitreous Anomalies1
  • Retinopathy Of Prematurity Both Eyes1
  • Retinal Vascular Disorder1

Activity Timeline